Britannia Life Sciences Inc. (BLSIF)
OTCMKTS · Delayed Price · Currency is USD
0.0606
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
Britannia Life Sciences Market Cap
Britannia Life Sciences has a market cap or net worth of $11.94 million as of February 12, 2026. Its market cap has increased by 33.04% in one year.
Market Cap
11.94M
Enterprise Value
13.10M
Revenue
187.08K
Ranking
n/a
PE Ratio
2.02
Stock Price
$0.06
Market Cap Chart
Since November 18, 2021, Britannia Life Sciences's market cap has decreased from 33.20M to 11.94M, a decrease of -64.04%. That is a compound annual growth rate of -21.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 11.94M | 12.11% |
| Dec 31, 2025 | 10.65M | 17.78% |
| Dec 19, 2024 | 9.04M | -1.87% |
| Dec 29, 2023 | 9.21M | 9.80% |
| Dec 30, 2022 | 8.39M | -63.05% |
| Dec 31, 2021 | 22.71M | -31.59% |
| Nov 18, 2021 | 33.20M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zeo ScientifiX | 18.28M |
| Provectus Biopharmaceuticals | 18.07M |
| TRON Group | 14.61M |
| HOOKIPA Pharma | 13.12M |
| Inhibitor Therapeutics | 10.01M |
| AccuStem Sciences | 9.16M |
| Biomind Labs | 8.84M |
| Curative Biotechnology | 7.94M |